Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
Evaluation of the efficacy of 3 doses of S066913 (5mg, 25mg, 100mg) versus placebo administered for 4 weeks on atrial fibrillation and/or atrial tachycardia burden in patients with paroxysmal atrial fibrillation who are potentially eligible for atrial fibrillation ablation and are implanted with insertable cardiac monitoring device.
Critère d'inclusion
- Paroxysmal atrial fibrillation